This multidisciplinary educational initiative is targeted to clinicians who care for people with MS including neurologists, nurses, nurse practitioners, physician assistants, and pharmacists.
Alemtuzumab, cerebrolspinal fluid, central vein sign, cladribine, clinically isolated syndrome, disease-modifying therapy, fingolimod, Gd+ lesions, glatiramer acetate, interferon-beta, magnetic resonance imaging, McDonald criteria, multiple sclerosis, natalizumab, neurofilament
Edward Fox, MD, PhD, FAAN
Director, MS Clinic of Central Texas
Central Texas Neurology Consultants, PA
Clinical Associate Professor of Neurology
University of Texas Dell Medical School
Round Rock, TX
Edward Fox, MD, PhD, FAAN, is Director of the Multiple Sclerosis (MS) Clinic of Central Texas and the founding partner of Central Texas Neurology Consultants in Round Rock, Texas. Dr Fox also has an appointment as Clinical Associate Professor of Neurology at the University of Texas Dell Medical School in Austin, Texas. After receiving a bachelor’s degree at Washington University in St. Louis, Missouri, he was enrolled in the Medical Scientist Training Program at Baylor College of Medicine in Houston, Texas, where he earned a dual medical degree and a doctorate in immunology for the thesis, “Growth Requirements of Human Suppressor T Lymphocytes.”
Since starting a private neurology practice in the Austin area in 1992, Dr Fox has been involved in numerous MS research protocols and is an international speaker on topics related to neuroimmunology. He is a Fellow of the American Academy of Neurology and his clinic has been designated a Center for Comprehensive MS Care by the National MS Society. Dr Fox is a longstanding member of the Consortium of MS Centers and is President-Elect of the Texas Neurological Society.
Stephanie A. Agrella, PhDc, MSN, RN, ANP-BC, MSCN
Director of Clinical Services
Multiple Sclerosis Clinic of Central Texas
Round Rock, TX
Jacquelyn L. Bainbridge, BSPharm, PharmD, FCCP, MSCS, FAES
Professor, Department of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
Professor, Department of Neurology
Anschutz Medical Campus
University of Colorado
Aurora, CO
Jacquelyn L. Bainbridge, BSPharm, PharmD, FCCP, MSCS, FAES, is a Professor at the University of Colorado Anschutz Medical Campus, where she holds joint appointments in the Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, and the Department of Neurology in the School of Medicine. Dr Bainbridge received her doctorate in pharmacy from the University of Colorado in Denver, where she subsequently completed a specialty residency in neurology.
Dr Bainbridge is a Multiple Sclerosis Certified Specialist (MSCS) and is actively involved in clinical research in many areas of neurology, including epilepsy, multiple sclerosis (MS), Parkinson’s disease (PD), back pain, and cannabis. Currently, she is working on 2 clinical trials investigating cannabis for the treatment of back pain and PD sponsored by the Colorado Department of Public Health and Environment (CDPHE), as well as a synthetic cannabidiol (CBD) study involving patients with Fragile X syndrome. Dr Bainbridge is involved in 2 additional clinical trials sponsored by the CDPHE: one for back pain in patients not on opiates or on opiates with a dose reduction and cannabis treatment, and another study in patients with autism being treated with CBD for behavioral issues. Dr Bainbridge also continues to study the safety and efficacy of antiepileptic drugs in older adults. She was previously an investigator for several National Institutes of Health (NIH)-funded trials researching drugs that may be neuroprotective in PD. Dr Bainbridge has completed a clinical trial using a synthetic CBD product in patients with scleroderma.
She has published several articles in professional journals, including Epilepsia, Pharmacotherapy, and the American Journal of Health-System Pharmacy. She has reviewed and written several book chapters on MS, epilepsy, migraine, chronic pain, women’s issues, pharmacokinetics, and the practice of pharmacy. Dr Bainbridge is a frequent lecturer on topics of neurologic and pharmacologic interest, including chronic pain disorders, epilepsy, migraines, movement disorders, MS, neuroprotection, restless legs syndrome, and the administration of cannabis for therapeutic intent.
Dr Bainbridge is a member of numerous professional organizations, including the Epilepsy Foundation of Colorado, the American Academy of Neurology, the American Epilepsy Society, the Epilepsy Foundation of America, the American College of Clinical Pharmacy, the American Association of Colleges of Pharmacy, the Colorado Pharmacists Society, and the American Society of Health-System Pharmacists. She is the past president of the board of directors for the Restless Legs Syndrome Foundation and is a member of the Epilepsy Foundation of Colorado professional advisory board. Dr Bainbridge was elected as a Fellow of the American College of Clinical Pharmacy (FCCP) and a Fellow of the American Epilepsy Society (FAES), and has won several student preceptor and teaching awards.1. | Evaluate clinical data on the use of magnetic resonance imaging (MRI), cerebrospinal fluid (CSF), and blood biomarkers for early detection of multiple sclerosis (MS) |
1. | Evaluate clinical data on the use of magnetic resonance imaging (MRI), cerebrospinal fluid (CSF), and blood biomarkers for early detection of multiple sclerosis (MS) |
Spire Learning
Jeanne Prater
Shareholder (spouse/partner): Johnson & Johnson
Employee (spouse/partner: Novo Nordisk
Chris Washburn, PhD
Employee (spouse/partner): Janssen Pharmaceuticals, Inc
Lisa Colombo has disclosed no relevant financial relationships with any commercial interests.
Contact Information: If you have any questions relating to the accreditation of this activity, please contact Lisa Colombo, Spire Learning, lcolombo@optonline.net.
All planning committee members also served as reviewers.
Reviewers
June Halper, MSN, APN-C, MSCN, FAAN
CEO, Consortium of Multiple Sclerosis Centers
Hackensack, NJ
Laurie Scudder, DNP, NP, served as a planner and reviewer for this activity. She has disclosed no relevant financial relationships.
All other CMSC and Spire staff who are in a position to influence content have disclosed no relevant financial relationships.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of therapies that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, participants are encouraged to consult appropriate resources for any product or device mentioned in this program.
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
For video playback, install the latest version of Flash or Quicktime.